Larry Alexander Gaither
7Patents
1h-index
4Co-inventors
36Inventor score
Filing activity: Jan 26, 2012 → Nov 29, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8603995B2 | dsRNA for treating viral infection | Emerging Cross-Sectional Technologies | 5 | Active |
| US10695333B2 | Pharmaceutical combination comprising LSZ102 and alpelisib | Chemistry; Metallurgy | 1 | Active |
| US8748587B2 | Molecules and methods for modulating TMEM16A activities | Chemistry; Metallurgy | 1 | Active |
| US10273482B2 | dsRNA for treating viral infection | Emerging Cross-Sectional Technologies | 0 | Active |
| US11179365B2 | Pharmaceutical combination comprising LSZ102 and ribociclib | Human Necessities | 0 | Active |
| US9045546B2 | Molecules and methods for modulating TMEM16A activities | Chemistry; Metallurgy | 0 | Active |
| US9133462B2 | dsRNA for treating viral infection | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.